Full Coverage
Track 1000+ biotech and pharma stocks listed in the U.S. without building or maintaining a manual list.
- No market-cap restrictions
- Focused coverage within one industry
- Understand why a stock is moving
Real-time biotech intelligence
Track market-moving news from official sources and receive critical updates within minutes. BioPharmSignal is built for investors who want a cleaner, faster way to follow biotech catalysts.
Coverage
1000+ U.S.-listed biotech and pharma stocks
Sources
Press releases, SEC filings, FDA updates, trial results
Delivery
Critical alerts delivered within 5 minutes
What it does
BioPharmSignal reduces the work of monitoring biotech catalysts by keeping the highest-signal updates in one focused product.
Full Coverage
Official Sources
Real-time News
Notification
Notification keeps delivery immediate and lightweight. You do not need to monitor inboxes or refresh multiple tabs to catch important biotech catalysts. When BioPharmSignal is added to the phone home screen, the same notification flow can also reach mobile.
Critical biotech headlines arrive directly in the browser as they happen.
When the page is added to a phone home screen, the same push flow can surface on mobile too.
No inbox checking, no tab hunting, and no extra workflow to catch important catalysts.
Message notification
biopharmsignal.com
You have a new biotech catalyst alert, please review promptly
Saved app
BioPharmSignal
Investor Fit
BioPharmSignal is built for users who already follow the events that drive biotech prices and want a cleaner way to stay current.
1000+
stocks covered
5 min
delivery target
24/7
monitoring
BioPharmSignal is designed to surface critical biotech headlines within minutes whenever possible, especially for company press releases, FDA updates, SEC filings, and clinical trial news.
No. Coverage is automatic across the U.S.-listed biotech and pharma universe, so you can start with the livefeed and then narrow the view using saved tickers and keywords when needed.
BioPharmSignal focuses on high-signal official and near-official sources, including company press releases, SEC filings, FDA updates, and clinical trial headlines that can move biotech stocks.
The product is built for biotech investors, operators, and teams that need fast awareness of catalyst-driven updates without monitoring dozens of investor relations pages manually.
Yes. BioPharmSignal supports saved tickers and keywords so you can focus on a small watchlist, a handful of catalysts, or a broader theme such as obesity, oncology, or gene editing.
Typical events include FDA decisions, PDUFA-related headlines, clinical readouts, partnership announcements, financing news, SEC filings, launch updates, and other catalyst-style company news.